论文部分内容阅读
急性混合细胞白血病(AMLL)是指涉及2个或2个以上造血细胞系列的特殊类型白血病,可能起源早期的造血干细胞。其发病率低,治疗缓解率低,生存期短,预后凶险。本文根据骨髓细胞形态学、化学染色和免疫表型结果诊断AML,评价化疗疗效及影响疗效的相关因素。结果研究发现,AMLL 可有发热、贫血、淋巴结肿大、肝脾肿大等临床表现。半数患者属高白细胞白血病。所有患者骨髓增生明显
Acute mixed-cell leukemia (AMLL) refers to a specific type of leukemia involving two or more hematopoietic cell lines that may have originated in the early stage of hematopoietic stem cells. Its low incidence, low response rate of treatment, short survival, prognosis dangerous. This article based on bone marrow cell morphology, chemical staining and immunophenotypic diagnosis of AML to evaluate the efficacy and efficacy of chemotherapy related factors. Results The study found that AMLL may have fever, anemia, lymph nodes, hepatosplenomegaly and other clinical manifestations. Half of patients with high white blood cell leukemia. All patients with bone marrow hyperplasia